Xylos Corporation

Xylos Corporation is a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. Our proprietary biocellulose technology possesses the effectiveness, versatility and safety profile to address a broad range of medical applications including surgical implants for musculoskeletal, urological / gynecological, abdominal, cardiovascular, oral / maxillofacial and plastic / aesthetics indications representing an aggregate market opportunity of $4 billion. Additionally, our biomaterial has unique drug delivery properties that have been demonstrated via in vitro and clinical evaluations. To focus our efforts and resources, we are concentrating on the development of select surgical implants for the musculoskeletal field, targeting a U.S. market opportunity of $1 billion.

• Employees 2